IDYA
Price
$23.10
Change
+$0.69 (+3.08%)
Updated
Aug 8 closing price
Capitalization
2.02B
93 days until earnings call
RNA
Price
$46.29
Change
-$1.23 (-2.59%)
Updated
Aug 8 closing price
Capitalization
5.58B
93 days until earnings call
Interact to see
Advertisement

IDYA vs RNA

Header iconIDYA vs RNA Comparison
Open Charts IDYA vs RNABanner chart's image
IDEAYA Biosciences
Price$23.10
Change+$0.69 (+3.08%)
Volume$849.96K
Capitalization2.02B
Avidity Biosciences
Price$46.29
Change-$1.23 (-2.59%)
Volume$4.93M
Capitalization5.58B
IDYA vs RNA Comparison Chart in %
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDYA vs. RNA commentary
Aug 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Hold and RNA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 10, 2025
Stock price -- (IDYA: $23.10 vs. RNA: $46.29)
Brand notoriety: IDYA and RNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 82% vs. RNA: 188%
Market capitalization -- IDYA: $2.02B vs. RNA: $5.58B
IDYA [@Biotechnology] is valued at $2.02B. RNA’s [@Biotechnology] market capitalization is $5.58B. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whileRNA’s FA Score has 0 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • RNA’s FA Score: 0 green, 5 red.
According to our system of comparison, RNA is a better buy in the long-term than IDYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 3 TA indicator(s) are bullish while RNA’s TA Score has 6 bullish TA indicator(s).

  • IDYA’s TA Score: 3 bullish, 5 bearish.
  • RNA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, RNA is a better buy in the short-term than IDYA.

Price Growth

IDYA (@Biotechnology) experienced а -4.82% price change this week, while RNA (@Biotechnology) price change was +28.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.25%. For the same industry, the average monthly price growth was +6.85%, and the average quarterly price growth was +13.24%.

Reported Earning Dates

IDYA is expected to report earnings on Nov 11, 2025.

RNA is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+0.25% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNA($5.58B) has a higher market cap than IDYA($2.03B). RNA YTD gains are higher at: 59.182 vs. IDYA (-10.117). IDYA has higher annual earnings (EBITDA): -356.46M vs. RNA (-430.35M). RNA has more cash in the bank: 1.38B vs. IDYA (693M). RNA has less debt than IDYA: RNA (5.97M) vs IDYA (26M). RNA has higher revenues than IDYA: RNA (8.93M) vs IDYA (7M).
IDYARNAIDYA / RNA
Capitalization2.03B5.58B36%
EBITDA-356.46M-430.35M83%
Gain YTD-10.11759.182-17%
P/E RatioN/AN/A-
Revenue7M8.93M78%
Total Cash693M1.38B50%
Total Debt26M5.97M435%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
75
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IDYARNA
RSI
ODDS (%)
Bearish Trend 3 days ago
70%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 4 days ago
83%
MACD
ODDS (%)
Bearish Trend 3 days ago
73%
Bullish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 18 days ago
77%
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CHCGX57.810.47
+0.82%
Chesapeake Growth
FLUIX28.650.19
+0.67%
Fidelity Advisor Stk Selec Lg Cp Val I
CFVLX33.500.19
+0.57%
Commerce Value
DDVCX14.120.07
+0.50%
Macquarie Value C
VFSNX263.040.41
+0.16%
Vanguard FTSE All-Wld ex-US SmCp Idx Ins